ATS (ATS) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced with a welcome, recording notice, and cautionary statements regarding forward-looking information and non-IFRS measures.

• Chair introduced board members and outlined the agenda, including director elections, auditor reappointment, executive compensation advisory vote, and a shareholder proposal.

Board and executive committee updates

• Chair highlighted dissatisfaction with past performance and a renewed focus on value creation and risk mitigation.

• Management team strengthened, including new leadership in Life Sciences and a focus on lean continuous improvement.

Strategic initiatives and plans

• Emphasis on deepening the ATS Business Model (ABM) for margin improvement over the next 18 months.

• Focus on increasing aftermarket sales and service revenue to approach best-in-class levels, with aftermarket revenue already outpacing equipment sales.

• Plans to return to organic growth through technology investments and targeting high-growth markets such as small modular reactors and medical devices.

• Deleveraging achieved, enabling larger M&A opportunities as industry consolidation is anticipated over the next two years.